(Q40612379)

English

Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival

scientific article published on November 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 September 2017

Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival (English)

1 reference

Europe PubMed Central

22 September 2017

periampullary adenocarcinoma

1 reference

based on heuristic

inferred from title

author name string

Chakravarthy A

1

1 reference

Europe PubMed Central

22 September 2017

Abrams RA

2

1 reference

Europe PubMed Central

22 September 2017

Yeo CJ

3

1 reference

Europe PubMed Central

22 September 2017

Korman LT

4

1 reference

Europe PubMed Central

22 September 2017

Donehower RC

5

1 reference

Europe PubMed Central

22 September 2017

Hruban RH

6

1 reference

Europe PubMed Central

22 September 2017

Zahurek ML

7

1 reference

Europe PubMed Central

22 September 2017

Grochow LB

8

1 reference

Europe PubMed Central

22 September 2017

O'Reilly S

9

1 reference

Europe PubMed Central

22 September 2017

Hurwitz H

10

1 reference

Europe PubMed Central

22 September 2017

Jaffee EM

11

1 reference

Europe PubMed Central

22 September 2017

Lillemoe KD

12

1 reference

Europe PubMed Central

22 September 2017

Cameron JL

13

1 reference

Europe PubMed Central

22 September 2017

language of work or name

0 references

publication date

1 November 2000

1 reference

Europe PubMed Central

22 September 2017

International Journal of Radiation Oncology Biology Physics

1 reference

Europe PubMed Central

22 September 2017

48

1 reference

Europe PubMed Central

22 September 2017

1089-1096

1 reference

Europe PubMed Central

22 September 2017

4

1 reference

Europe PubMed Central

22 September 2017

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900755-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: pathology, complications, and outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900755-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant therapy with chemotherapy and radiation therapy in the management of carcinoma of the pancreatic head.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900755-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900755-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900755-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Periampullary adenocarcinoma: analysis of 5-year survivors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900755-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900755-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900755-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900755-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Split course radiation therapy for adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900755-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900755-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900755-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluorouracil and high-dose leucovorin in previously untreated patients with advanced adenocarcinoma of the pancreas: results of a phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900755-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Early evaluation of abdominal/hepatic irradiation and 5-fluorouracil/leucovorin infusion after pancreaticoduodenectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900755-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Failure of orally administered dipyridamole to enhance the antineoplastic activity of fluorouracil in combination with leucovorin in patients with advanced colorectal cancer: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900755-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of leucovorin and dipyridamole on fluoropyrimidine-induced radiosensitization.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900755-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of 5-fluorouracil and mitomycin C with or without streptozotocin for advanced pancreatic cancer. A Southwest oncology group study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900755-0

7 January 2021

based on heuristic

inferred from DOI database lookup

5-fluorouracil, Adriamycin, and mitomycin-C (FAM) chemotherapy for advanced adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900755-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900755-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant therapy for pancreatic cancer: back to the future

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900755-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Gemcitabine and radiosensitization in human tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900755-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Anti-tumor effects of local irradiation in combination with peritumoral administration of low doses of recombinant interleukin-2 (rIL-2)

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900755-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase I clinical trial of lethally irradiated allogeneic pancreatic tumor cells transfected with the GM-CSF gene for the treatment of pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900755-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0360-3016(00)00755-0

1 reference

Europe PubMed Central

22 September 2017

1 reference

Europe PubMed Central

22 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40612379&oldid=1903653350"